Sign in

CIK 0001840229

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 4 Grant or award Director acquired 10,531 shares (grant or award)
  2. 4 Grant or award Director acquired 12,244 shares (grant or award)
  3. 4 Grant or award Director acquired 9,846 shares (grant or award)
  4. 4 Grant or award Director acquired 12,158 shares (grant or award)
  5. 4 Grant or award Director acquired 9,590 shares (grant or award)
  6. 4 Open-market buy 10% owner bought 29,678 shares at $1.52 ($45,016)
  7. 4 Open-market buy 10% owner bought 183,052 shares at an average $1.54 ($281,478)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 10,157 shares (grant or award)
  14. 4 Grant or award Director acquired 10,086 shares (grant or award)
  15. 4 Grant or award Director acquired 8,736 shares (grant or award)
  16. 4 Grant or award Director acquired 7,955 shares (grant or award)
  17. 4 Grant or award Director acquired 8,168 shares (grant or award)
  18. 4/A Insider Changes in Ownership
  19. 4/A Insider Changes in Ownership
  20. 4/A Other disposition 10% owner disposed of 5,006,397 shares (other)

Page 5 of 8 · 145 filings